Condition
Acute Heart Failure (AHF) clinical trials and research
As of November 12, 2026, Find a Trial lists 20 Acute Heart Failure (AHF) clinical trials that are recruiting, at sites in 13 countries (most in Spain (4), Denmark (3), France (2)). By phase: Phase 4 (4), Phase 2 (1). The most active sponsors are Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal (3), University of Aarhus (2), Wroclaw Medical University (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 20Clinical trials
- 13Countries
Newest Acute Heart Failure (AHF) clinical trials
All recruiting trials (20)
-
Comprehensive clinical rule to diagnose acute heart failure in the emergency department
A prospective study tests a combined clinical rule using patient data, a point-of-care NT-proBNP test, an 8-point lung ultrasound, and bedside echo to quickly diagnose acute heart failure in adults with new or worsening symptoms.
-
Disrupted congestion in acute heart failure: can ultrasound at discharge predict readmission and death
This study tests whether ultrasound checks of congestion at discharge can predict which patients with acute heart failure are more likely to be readmitted or die within 90 days.
-
Pre-discharge Flu Vaccine for patients with acute heart problems
This trial tests whether giving an influenza vaccine within 24 hours before hospital discharge helps patients who were treated for acute heart issues stay healthier this season.
-
Acute Heart Failure: How a Quantitative ECG Helps Clinicians
This study tests whether quantitative ECG (QCG) measurements can reveal useful patterns in adults hospitalized with acute heart failure.
-
Urinary Sodium and Chloride Changes and Fluid Overload in Acute Heart Failure
This study tests whether tracking urinary sodium and chloride during hospitalization can reflect congestion removal and predict short-term outcomes in adults with acute heart failure treated with IV diuretics.
-
Training medical residents to use the Venous Excess Ultrasound (VExUS) score for bedside volume assessment
This project tests whether in-person or remote training better teaches medical residents to use the VExUS ultrasound score for bedside volume checks in patients with acute heart failure.
-
Sarcopenia in older adults with acute heart failure: using muscle ultrasound and biomarkers to predict outcomes
This study tests whether measuring muscle mass with ultrasound, along with muscle strength and biomarkers, can help predict outcomes for adults 80 and older hospitalized for acute heart failure with preserved ejection fraction.
-
Prolonged nasogastric ketone infusion for decompensated heart failure
This will test whether a continuous nasogastric infusion of a ketone (D‑beta‑hydroxybutyrate) can safely reach target blood levels in adults with severely reduced ejection fraction admitted for acute decompensated heart failure or cardiogenic shock.
-
Multimodal profiling of adults hospitalized with acute heart failure and cardiogenic shock
This project will test whether combining routine hospital data with extra blood and urine samples can help doctors identify types of cardiogenic shock and predict 30-day outcomes in adults hospitalized with acute heart failure.
-
Screening for blood clots in adults with acute heart failure
This trial tests whether a guideline-based screening approach can detect pulmonary embolism in adults admitted with acute heart failure.
-
ReDS-guided decongestion for people hospitalized with heart failure
This test will see if using a ReDS chest sensor to guide fluid removal helps adults hospitalized for heart failure have fewer heart-related problems in the month after discharge.
-
Fibroscan use to help diagnose acute heart failure in the emergency department
This study tests whether a FibroScan device can quickly help doctors identify acute heart failure in adults who come to the ED with sudden shortness of breath.
-
Restrictive versus liberal fluid intake for patients hospitalized with acute heart failure
This study will try whether a thirst-driven, liberal drinking plan works as well as a fluid-restriction plan for adults hospitalized with acute decompensated heart failure.
-
Low-dose digoxin after an episode of acute heart failure
This study tests whether adding low-dose digoxin to standard heart failure medicines helps adults with reduced ejection fraction who recently stabilized after hospitalization feel better and be 'Alive and Well' at 180 days.
-
Using urine sodium to guide IV diuretic dosing for hospitalized acute heart failure
This trial will test whether increasing IV diuretic doses to reach higher urine sodium levels helps hospitalized adults with acute decompensated heart failure remove more salt and fluid and have fewer readmissions.
-
Temporary heart support with the iVAC 2L device during high-risk coronary procedures
This trial will try the iVAC 2L temporary heart‑support device during high‑risk PCI to help people with severe coronary artery disease stay hemodynamically stable through the procedure.
-
Urine-based algorithm to personalize diuretics for fluid relief in acute heart failure
This will test whether a urine-composition algorithm can guide IV diuretics to help adults hospitalized with acute heart failure remove excess fluid more effectively.
-
Evaluating residual congestion in patients with acute heart failure at discharge
This study is testing new ways to check for leftover fluid in patients with acute heart failure when they leave the hospital to see if it can help predict their recovery better.
-
Using ketone supplements to treat patients with acute heart failure
This study is testing if a ketone supplement can help people in the hospital with acute heart failure feel better and improve their heart function compared to a placebo.
-
Vietnamese rapid protocol to speed up the four main heart-failure medicines for people with reduced ejection fraction
This program tests whether starting and quickly increasing the four key heart-failure medicines before discharge and during early outpatient follow-up helps adults hospitalized with reduced ejection fraction and high NT‑proBNP.
Related topics
Quick answers
How many Acute Heart Failure (AHF) clinical trials are recruiting right now?
20, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 13 countries. The most sites are in Spain (4 trials), Denmark (3 trials), France (2 trials), Poland (2 trials), Argentina (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 4, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.